When 90% of S&P 500 company value sits in intangible assets[1], lending against buildings and equipment starts to look like an outdated strategy. The gap between where corporate value lives and where lenders are willing to collateralize is widening, and a growing number of institutions are stepping into that gap with intellectual property-backed financing.
For alternative lenders already comfortable underwriting non-traditional assets, IP-backed lending represents a natural next frontier.
The IP Lending Boom
Global IP-asset valuations rose from $61 trillion to $74 trillion between 2019 and 2021, reflecting the accelerating shift toward intangible corporate value.[2]
The market has responded accordingly. In China alone, more than 26,000 businesses received IP-backed loans in 2022, totaling 401.5 billion yuan (approximately $55 billion).[3] That is not a pilot program. That is a functioning market at scale.
Europe and Southeast Asia are rapidly emerging as high-growth regions, joining North America and China as primary markets.[4] Early-stage patent financing is gaining particular traction in high-tech, electronics, and biopharmaceuticals, where companies hold substantial patent portfolios but limited hard assets. Firms like BlueIron IP[5], eCapital[6], and Triangle IP[7] are building specialized practices around this asset class.
Industry practitioners now describe IP lending as "no longer in its infancy but has grown to be a unique differentiator" for lenders willing to develop the expertise.
How IP-Backed Lending Works
IP-backed lending uses patents, trademarks, copyrights, or trade secrets as collateral to secure financing. The process differs meaningfully from traditional asset-based lending.
Valuation is the first and most complex step. Unlike real estate, which benefits from comparable sales data and established appraisal methodologies, IP requires specialized approaches: the cost approach (what it cost to develop), the market approach (what comparable IP has sold for), and the income approach (projected future revenue).[8] Each carries its own assumptions and limitations.
Collateral structure typically involves a UCC security interest filing plus a recording with the relevant federal agency. Patents and trademarks go through the USPTO; copyrights through the U.S. Copyright Office. Missing either filing can create enforcement gaps.[9]
Enforcement in default presents unique challenges. Foreclosing on a patent is not the same as seizing equipment. The lender must transfer ownership, find a buyer, and navigate challenges from borrowers or third parties. Cross-jurisdictional enforcement adds complexity when IP rights span multiple countries.
Lenders are also exploring crossover IP baskets that merge patents, trade secrets, and proprietary software into a single collateral package, diversifying within the intangible asset category.
The Opportunity for Alternative Lenders
For MCA providers, factoring companies, and equipment finance firms, IP-backed lending opens a substantial new market segment: technology companies with strong IP portfolios but limited tangible assets.
Consider a biotech startup with three granted patents and a pending FDA pathway but no real estate, no equipment, and minimal receivables. Under traditional criteria, this company is nearly unfundable. Under an IP-backed framework, those patents represent quantifiable, transferable value.
New borrower segments. Technology, pharmaceutical, and software companies are underserved by traditional asset-based lending. They often have strong revenue trajectories and valuable IP but fail conventional collateral requirements.
Portfolio diversification. IP values do not necessarily correlate with real estate market cycles, providing a potential hedge against sector-specific downturns.
Higher yields. The specialized nature of IP lending, combined with fewer competitors, typically commands higher interest rates and fees.
The Challenges
IP-backed lending carries significant risks that require clear-eyed assessment.
Valuation complexity remains the primary barrier. There is no MLS for patents. Comparable transaction data is sparse, and the income approach relies on projections that may never materialize. A patent worth $10 million on paper could lose most of its value if the technology becomes obsolete.
Rapid depreciation affects certain IP types acutely. Software patents lose value as technology evolves. Pharmaceutical patents have defined expiration dates. Trade secrets can be compromised by employee departures. Collateral value can shift faster than traditional asset classes.
Legal enforcement across jurisdictions fragments recovery. Patent rights are territorial. A U.S. patent provides no protection in Europe or Asia, and borrowers with international operations may hold IP across multiple legal systems.
Thin secondary markets mean finding a buyer at fair value is not guaranteed. The pool of potential acquirers for a specific patent portfolio can be extremely small, giving buyers significant leverage in any distressed sale.
The Entity Verification Foundation
Before evaluating a patent portfolio as collateral, there is a more fundamental question: does the borrowing entity actually own the IP it claims to hold, and is that entity legally authorized to transact?
Patent ownership is recorded at the USPTO and tied to a specific legal entity. If the borrowing entity is dissolved, suspended, or not in good standing in its state of incorporation, it cannot legally hold or transfer IP rights. A lender who accepts IP collateral from a legally impaired entity risks discovering that the entire collateral package is unenforceable.
Entity verification must come first. Confirming that the business is active, in good standing with its Secretary of State, and operating under the correct legal name is the baseline requirement before any IP due diligence begins.
What Comes Next
IP-backed lending will not replace real estate as the default collateral class. But for alternative lenders looking to serve technology-driven businesses, it represents a meaningful and expanding opportunity.
The lenders who succeed here will invest in three things: specialized IP valuation expertise, strong legal frameworks for collateral enforcement, and reliable entity verification processes that confirm the borrower's legal standing before any deal moves forward.
The corporate world has already shifted its value from tangible to intangible assets. The lending industry is beginning to follow.
Need real-time entity verification for your lending operation? Talk to Cobalt Intelligence about automated Secretary of State business verification across all 50 states.
.jpg){kind=small}
.png)